Safety of interferon‐free therapies for chronic hepatitis C: a network meta‐analysis

E-ISSN： 1365-2710|41|5|478-485

ISSN： 0269-4727

Source： JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol.41, Iss.5, 2016-10, pp. : 478-485

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systematic review with meta‐analysis: effectiveness and tolerability of interferon‐free direct‐acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 5, 2018-03 ,pp. : 550-562

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interferon‐free antiviral treatment of chronic hepatitis C in the transplant setting

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 9, 2015-09 ,pp. : 1011-1024

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interferon‐free, direct‐acting antiviral therapy for chronic hepatitis C

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 1352-0504, Iss. 11, 2015-11 ,pp. : 861-870

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interferon‐free, direct‐acting antiviral therapy for chronic hepatitis C

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 11, 2015-11 ,pp. : 861-870

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interferon‐free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND‐C3, a Phase 2b study

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 2, 2015-02 ,pp. : 417-421

John Wiley & Sons Inc

Access to resources Recommend Favorite